Dobek Maria
SEC insider (Form 3/4/5 filer). CIK 0002032671. Vice President, Accounting at Janux Therapeutics, Inc. (JANX). 4 reported Form 4/5 transactions since Sep 2024; latest on May 11, 2026. Located in SAN DIEGO, CA.
Companies Dobek Maria has filed insider reports for
- Janux Therapeutics, Inc. (JANX): Officer, Vice President, Accounting
Dobek Maria
CIK: 0002032671
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JANX
Janux Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 11, 2026JANX
Janux Therapeutics, Inc.
SaleDirect2K shares at avg. $14.17$29K - Jan 2, 2026JANX
Janux Therapeutics, Inc.
SaleDirect1.5K shares at avg. $13.73$20K - Jan 2, 2026JANX
Janux Therapeutics, Inc.
AwardDirect18.9K shares- - Jan 2, 2025JANX
Janux Therapeutics, Inc.
AwardDirect14K shares-
1-4 of 4 transactions